AWM
PPH icon

Accredited Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Accredited Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9.04K Sell
20
-80
-80% -$7.01K 0.01% 274
2025
Q2 		$8.8K Hold
100
– – 0.01% 274
2025
Q1 		$9.11K Hold
100
– – 0.01% 250
2024
Q4 		$8.63K Buy
+100
New +$9.04K 0.01% 259

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Accredited Wealth Management's PPH Position: Q3 2025 in Review

Accredited Wealth Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 80% in Q3 2025, selling an estimated $7.01K and leaving 20 shares worth $9.04K. The position accounts for 0.01% of the portfolio, ranked #274.

Accredited Wealth Management first reported a position in PPH in Q4 2024 and has held it in 4 quarters since. The position peaked at $9.11K in Q1 2025. 127 funds tracked by Wall St. Rank hold PPH as of Q3 2025.

  • Accredited Wealth Management held 20 shares of VanEck Pharmaceutical ETF worth $9.04K as of Q3 2025.
  • Accredited Wealth Management sold 80 VanEck Pharmaceutical ETF shares in Q3 2025, an estimated $7.01K.
  • VanEck Pharmaceutical ETF made up 0.01% of Accredited Wealth Management's portfolio in Q3 2025, its #274 holding.
  • Accredited Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2024 and has held it in 4 quarters since.
  • Accredited Wealth Management's VanEck Pharmaceutical ETF position peaked at $9.11K in Q1 2025.
  • 127 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2025.

Based on Accredited Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.